{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:24:17Z","timestamp":1750526657637},"reference-count":12,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":10067,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1981,10]]},"abstract":"<jats:p>102 patients with chronic lymphocytic leukaemia underwent clinical staging according to 2 systems: the Rai staging system with 5 stages (0: lymphocytosis, I: palpable lymph nodes, II: hepato\u2010 or splenomegaly, III: Hb below 110 g\/1, IV: platelet count below 100 times 10<jats:sup>9<\/jats:sup>\/1) was compared to a staging system recently proposed by Binet, with only 3 stages (A: not more than 2 areas of palpable nodes or organs, B: at least 3 areas, C: Hb below 10 g\/1 or platelet count below 100 times 19<jats:sup>9<\/jats:sup>\/1). With the 3\u2010stage system statistically significant differences between the stages were obtained, whereas some of the Rai stages (I\u2010II\u2010III) were only poorly separated. Non\u2010haemolytic anaemia with Hb below 100 g\/1 was associated with a far graver prognosis than milder anaemia (Hb between 100 and 110 g\/1) or auto\u2010immune haemolytic anaemia. Chest X\u2010ray findings did not influence the clinical stage.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1981.tb00485.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T23:29:07Z","timestamp":1280964547000},"page":"279-286","source":"Crossref","is-referenced-by-count":20,"title":["Chronic Lymphocytic Leukaemia: A Test of a Proposed New Clinical Staging System"],"prefix":"10.1111","volume":"27","author":[{"given":"C.","family":"Geisler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M\u00f8rk","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_2_1_3_1","article-title":"Writing commitee of the International Workshop on CLL) (1981b) Chronic lymphocytic leukemia: A proposal for a revised prognostic staging system","author":"Binet J L","journal-title":"Br J Haematol"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1182\/blood.V29.4.566.566","article-title":"Chronic lymphocytic leukemia \u2010an accumulative disease of immunological incompetent lymphocytes","volume":"29","author":"Dameshek W","year":"1967","journal-title":"Blood"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb05845.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(60)90062-X"},{"key":"e_1_2_1_8_1","first-page":"7","volume-title":"Cancer therapy: Prognostic factors and criteria","author":"Gehan E A","year":"1975"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.133.5.797"},{"key":"e_1_2_1_10_1","first-page":"1","article-title":"Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time","volume":"18","author":"Hansen M M","year":"1973","journal-title":"Scand J Haematol (Suppl)"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21979"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197808)42:2 <941::AID-CNCR2820420717>3.0.CO;2-1"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1981.tb00485.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1981.tb00485.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:59:09Z","timestamp":1699462749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1981.tb00485.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,10]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1981,10]]}},"alternative-id":["10.1111\/j.1600-0609.1981.tb00485.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1981.tb00485.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1981,10]]}}}